Literature DB >> 1335021

The molecular biology of poliovaccines.

P D Minor1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335021     DOI: 10.1099/0022-1317-73-12-3065

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  54 in total

1.  Enterovirus surveillance of Italian healthy children.

Authors:  A M Patti; A L Santi; L Fiore; L Vellucci; D De Stefano; E Bellelli; S Barbuti; G M Fara
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.

Authors:  Minetaro Arita; Shuang-Li Zhu; Hiromu Yoshida; Tetsuo Yoneyama; Tatsuo Miyamura; Hiroyuki Shimizu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Vaccine derived bi- and multi-recombinant Sabin strains.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Eugenia Bolanaki; Aris Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2007-08-07       Impact factor: 2.332

7.  Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.

Authors:  Franck B Riquet; Claire Blanchard; Sophie Jegouic; Jean Balanant; Sophie Guillot; Marie-Anne Vibet; Mala Rakoto-Andrianarivelo; Francis Delpeyroux
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 8.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

9.  Coxsackievirus B3 infection and its mutation in Keshan disease.

Authors:  Li-Qun Ren; Xiang-Jun Li; Guang-Sheng Li; Zhi-Tao Zhao; Bo Sun; Fei Sun
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

10.  A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.

Authors:  Ya-Fang Wang; Chun-Ting Chou; Huan-Yao Lei; Ching-Chuan Liu; Shih-Min Wang; Jing-Jou Yan; Ih-Jen Su; Jen-Reng Wang; Trai-Ming Yeh; Shun-Hua Chen; Chun-Keung Yu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.